A systematic review of cervical cancer incidence and mortality in the Pacific Region

Asian Pacific Journal of Cancer Prevention

Volumn 15, Issue 21, 2014, Pages 9433-9437

  Obel, J ^a,b   Souares, Y ^b   Hoy, D ^g   Baravilala, W ^c   Garland, S M ^d,e   Kjaer, S K ^f,g   Roth, A ^b  

^a HVIDOVRE HOSPITAL   (Denmark)

^b Research Evidence and Information Program Public Health Division Secretariat of the Pacific Community   (Thailand)

^c UNITED NATIONS POPULATION FUND   (United States)

^d ROYAL CHILDREN'S HOSPITAL   (Australia)

^e UNIVERSITY OF MELBOURNE   (Australia)

^f DANISH CANCER SOCIETY RESEARCH CENTER   (Denmark)

^g UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Cervical cancer; Human papillomavirus; Pacific

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; DEVELOPING COUNTRY; FEMALE; HUMAN; INCIDENCE; MIDDLE AGED; NEEDS ASSESSMENT; PACIFIC ISLANDS; PAPILLOMAVIRUS INFECTIONS; RISK ASSESSMENT; SURVIVAL; UTERINE CERVICAL NEOPLASMS; VIROLOGY;

ADULT; AGE DISTRIBUTION; AGED; DEVELOPING COUNTRIES; FEMALE; HUMANS; INCIDENCE; MIDDLE AGED; NEEDS ASSESSMENT; PACIFIC ISLANDS; PAPILLOMAVIRUS INFECTIONS; RISK ASSESSMENT; SURVIVAL ANALYSIS; UTERINE CERVICAL NEOPLASMS;

EID: 84918539628     PISSN: 15137368     EISSN: None     Source Type: Journal    
DOI: 10.7314/APJCP.2014.15.21.9433     Document Type: Article

References (29)

1. Ali H, Donovan B, Wand H, et al (2013). Genital warts in young Australians five years into national human papillomavirus vaccination programme: national surveillance data. BMJ, 346, 2032.
2. Brotherton JM, Friedman M, May CL, et al (2011). Early effect of the HPV vaccination programme on cervical abnormalities in Victoria, Australia: an ecological study. Lancet, 377, 2085-92.
3. Broutet N, Lehnertz N, Mehl G, et al (2013). Effective health interventions for adolescents that could be integrated with human papillomavirus vaccination programs. J Adolesc Health, 53, 6-13.
4. Brown DR, Kjaer SK, Sigurdsson K, et al (2009). The impact of quadrivalent human papillomavirus (HPV; types 6, 11, 16, and 18) L1 virus-like particle vaccine on infection and disease due to oncogenic nonvaccine HPV types in generally HPV-naive women aged 16-26 years. J Infect Dis, 199, 926-35.
5. Clifford GM, Smith JS, Aguado T, Franceschi S (2003). Comparison of HPV type distribution in high-grade cervical lesions and cervical cancer: a meta-analysis. Br J Cancer, 89, 101-5.
6. Secretariat of the Pacific Community (2011). Tahiti Nui Declaration [Online]. Available: http://www.spc.int/images/publications/ef/Corporate/ef-tahiti-nui-declaration.pdf (Accessed 10th of december 2013).
7. Denny L, Anorlu R (2012). Cervical cancer in Africa. Cancer Epidemiol Biomarkers Prev, 21, 1434-8.
8. Ferlay J, Shin HR, Bray F, et al (2010). Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer, 127, 2893-917.
9. Fesenfeld M, Hutubessy R, Jit M (2013). Cost-effectiveness of human papillomavirus vaccination in low and middle income countries: A systematic review. Vaccine, 31, 3786-804.
10. Foliaki S, Best D, Akau'ola S, et al (2011). Cancer incidence in four pacific countries: Tonga, Fiji Islands, Cook Islands and Niue. Pac Health Dialog, 17, 21-32.
11. Garland SM, Bhatla N, Ngan HY (2012). Cervical cancer burden and prevention strategies: Asia Oceania perspective. Cancer Epidemiol Biomarkers Prev, 21, 1414-22.
12. th of December 2013).
13. Goldie SJ, Diaz M, Kim SY, et al (2008). Mathematical models of cervical cancer prevention in the Asia Pacific region. Vaccine, 26, 17-29.
14. Haddock RL, Talon RJ, Whippy HJ (2006). Ethnic disparities in cancer mortality among residents of Guam. Asian Pac J Cancer Prev, 7, 411-4.
15. st August 2014).
16. Institute for Health Metrics and Evaluation (2013). Global Burden of Disease Study 2010 Results by Cause and Region 1990-2010 [Online]. Available: http://ghdx.healthmetricsandevaluation.org/record/global-burden-disease-study-2010-gbd-2010-results-cause-1990-2010 (Accessed May 2 2013).
17. Knaul FM, Bhadelia A, Gralow J, et al (2012). Meeting the emerging challenge of breast and cervical cancer in low-and middle-income countries. Int J Gynaecol Obstet, 119, 85-8.
18. Kuehn R, Fong J, Taylor R, Gyaneshwar R, Carter K (2012). Cervical cancer incidence and mortality in Fiji 2003-2009. Aust N Z J Obstet Gynaecol, 52, 380-6.
19. Law I, Fong J, Buandromo EM, et al (2013). The high burden of cervical cancer in Fiji, 2004-07. Sex Health, 10, 171-8.
20. Levin CE, Van Minh H, Odaga J, et al (2013). Delivery cost of human papillomavirus vaccination of young adolescent girls in Peru, Uganda and Viet Nam. Bulletin World Health Organization, 91, 585-92.
21. Moore MA, Baumann F, Foliaki S, et al (2010). Cancer epidemiology in the Pacific islands-past, present and future. Asian Pac J Cancer Prev, 1, 99-106.
22. Parkin DM, Louie KS, Clifford G (2008). Burden and trends of type-specific human papillomavirus infections and related diseases in the Asia Pacific region. Vaccine, 26, 1-16.
23. Paavonen J, Naud P, Salmeron J, et al (2009). Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women. Lancet, 374, 301-14.
24. Sahasrabuddhe VV, Parham GP, Mwanahamuntu MH, Vermund SH (2012). Cervical cancer prevention in low-and middle-income countries: feasible, affordable, essential. Cancer Prev Res, 5, 11-7.
25. Tabone T, Garland SM, Mola G, et al (2012). Prevalence of human papillomavirus genotypes in women with cervical cancer in Papua New Guinea. Int J Gynaecol Obstet, 117, 30-2.
26. Tabrizi SN, Law I, Buadromo E, et al (2011). Human papillomavirus genotype prevalence in cervical biopsies from women diagnosed with cervical intraepithelial neoplasia or cervical cancer in Fiji. Sex Health, 8, 338-42.
27. Tabrizi SN, Brotherton JM, Kaldor JM, et al (2014). Assessment of herd immunity and cross-protection after a human papillomavirus vaccination programme in Australia: a repeat cross-sectional study. Lancet Infect dis, [Epub ahead of print].
28. Vodonaivalu L, Bullen C (2013). Trends in cervical cancer in Fiji, 2000-2010. Public Health Action, 3, 68-71.
29. WHO 2009. Human papillomavirus vaccines: WHO position paper. Biologicals, 37, 338-44.